Gene Therapies: The Moment of Truth

Are physicians and patients ready?

Gene therapy: moment of truth | Ipsos | White paperOffering new hope to patients suffering certain conditions, gene therapies are a class of medicines which have the potential to transform how conditions are treated and may even provide a cure.

While only a handful are currently approved globally, a rich and diverse developmental pipeline suggests the stage is set for change.

In our latest point of view, we use data from our syndicated Global Therapy Monitor and Conference Assessment Studies to highlight potential knowledge gaps among treating physicians when it comes to gene therapies. We also offer recommendations on how these gaps could be bridged to help amplify both physician and patient adoption of these therapies in the future.

Download the full paper

Download

More insights about Health

Related news

  • [Webinar] KEYS: Battle For Attention
    Communication Events replay

    [Webinar] KEYS: Battle For Attention

    In an era dominated by ad-skipping, multi-screening, and media fragmentation, the challenge for today’s marketer is no longer just “Who am I reaching?” but “Am I reaching them at all?"
  • Where is metabolic medicine heading
    Healthcare Events replay

    Where is metabolic medicine heading – and what do you need to know?

    What happens when pipeline promise becomes market reality? During this PBSS webinar, Scott Morano and Roberto Cortese expertly guide viewers through the recent transformations in metabolic therapeutics for obesity, diabetes and MASH, and where the field is heading next.
  • KEYS: Screen time
    Media Measurement Events replay

    [WEBINAR] KEYS: Screen time

    At our first KEYS webinar of the year we’ll be looking at what’s really happening on screens these days. What’s changing? What’s enduring? And how can businesses do better when it comes to engaging with people on their screens, in real time?